Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:630 (22 March), doi:10.1136/bmj.39520.546678.3A
| The first 150 words of the full text of this article appear below. |
Ramaraj and Sorrell recommend antibiotic prophylaxis for infective endocarditis in all patients with aortic stenosis.1 This advice is not in accordance with the most recent guidelines by the American Heart Association on prevention of infective endocarditis.2 According to these guidelines, antibiotic prophylaxis is indicated only for certain cardiac conditions with the highest risk of infective endocarditis. These include prosthetic heart valves or prosthetic material used for cardiac valve repair, previous infective endocarditis, unrepaired cyanotic congenital heart disease (CHD), completely repaired congenital heart defect with prosthetic material, or CHD with residual defect at the site or adjacent to the site of a prosthetic patch, and cardiac transplant patients who develop cardiac valvulopathy. These guidelines are based on the results of latest research that indicate that few cases of infective endocarditis would be preventable with antibiotic prophylaxis, even with 100% effectiveness assumed.3 They also indicate that most patients with endocarditis on a
Habib U Rehman, clinical assistant professor
1 Regina QuAppelle Health Region, Regina, Saskatchewan, Canada S4S 0A5
habib31@sasktel.net